TBPH Operating Cash Flow
Theravance Biopharma Inc · Operating Cash Flow
TBPH Operating Cash Flow
Latest reported-$8.88Mperiod ending
TBPH Quarterly Operating Cash Flow (-$24.82M → -$8.88M)
Quarterly operating cash flow
High-resolution chart · PNG
TBPH operating cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| -8,881,000 | |
| 73,279,000 | |
| -6,064,000 | |
| -6,508,000 | |
| 208,074,000 | |
| 43,039,000 | |
| -902,000 | |
| -5,196,000 | |
| -4,415,000 | |
| -1,022,000 | |
| -854,000 | |
| -2,486,000 | |
| -12,436,000 | |
| -11,221,000 | |
| -124,055,000 | |
| -22,137,000 | |
| -14,730,000 | |
| -26,069,000 | |
| -42,434,000 | |
| -45,446,000 | |
| -50,113,000 | |
| -69,865,000 | |
| -64,925,000 | |
| -77,031,000 | |
| -53,346,000 | |
| -55,101,000 | |
| -64,352,000 | |
| -44,622,000 | |
| -48,030,000 | |
| -81,193,000 | |
| -52,178,000 | |
| -48,977,000 | |
| -61,537,000 | |
| 49,825,000 | |
| -44,202,000 | |
| -62,299,000 | |
| -44,525,000 | |
| -50,026,000 | |
| -28,113,000 | |
| -12,432,000 | |
| -32,135,000 | |
| -26,309,000 | |
| -33,746,000 | |
| -31,983,000 | |
| -46,614,000 | |
| -56,514,000 | |
| -42,539,000 | |
| -36,377,000 | |
| -51,440,000 | |
| -44,799,000 | |
| -35,188,000 | |
| -32,935,000 | |
| -24,345,000 | |
| -28,491,000 | |
| -22,707,000 | |
| -24,815,000 |